Blood Safety Authority Shift To CDRH Opposed By Blood Centers

Legislation shifting responsibility for the regulation of blood safety screening tests from FDA's Center for Biologics Evaluation and Research to the device center puts an enormous burden on blood organizations, according to America's Blood Centers (ABC)

More from Archive

More from Medtech Insight